drugset / Trial / NCT00755417

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

NCT00755417

Phase 3 Completed 541 enrolled Depomed
RandomizedParallel-groupTriple-blindTreatment

Summary

Depomed's Gabapentin Extended Release (G-ER) is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.

Timeline

Start
2008-09
Primary completion
2009-08
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg
Subject Gabapentin Small molecule 1800 mg

Indications

No indication recorded.